MIRONID LTD has a total of 14 patent applications. It decreased the IP activity by 75.0%. Its first patent ever was published in 2015. It filed its patents most often in United Kingdom, United States and EPO (European Patent Office). Its main competitors in its focus markets organic fine chemistry, pharmaceuticals and measurement are DOMAIN THERAPEUTICS, VIROSTATICS SRL and NAD AG.
# | Country | Total Patents | |
---|---|---|---|
#1 | United Kingdom | 4 | |
#2 | United States | 4 | |
#3 | EPO (European Patent Office) | 3 | |
#4 | WIPO (World Intellectual Property Organization) | 3 |
# | Industry | |
---|---|---|
#1 | Organic fine chemistry | |
#2 | Pharmaceuticals | |
#3 | Measurement | |
#4 | Biotechnology | |
#5 | Foods and drinks |
# | Technology | |
---|---|---|
#1 | Therapeutic chemical compounds | |
#2 | Heterocyclic compounds | |
#3 | Enzymes | |
#4 | Measuring microorganism processes | |
#5 | Analysing materials |
# | Name | Total Patents |
---|---|---|
#1 | Adam Julia Mary | 6 |
#2 | Adams David Roger | 6 |
#3 | Adam Julia | 4 |
#4 | Nandurdikar Rahul Shripad | 3 |
#5 | Kulkarni Santosh Shripad | 3 |
Publication | Filing date | Title |
---|---|---|
GB202102088D0 | Compounds and their use as pde4 activators | |
GB201805527D0 | Compounds and their use as pde4 activators | |
WO2018060704A1 | Compounds and their use as pde4 activators | |
GB201707680D0 | Phthalazinone and isoquinolnone derivatives as PDE4 inhibitors | |
GB201504763D0 | Compounds and uses |